CIK: 1591178 - Address: C/O Lyell Immunopharma, Inc., 201 Haskins Way, Suite 101, South San Francisco, CA 94080
22 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

S%ret2114-2-0-7-13-20-33-12
S%wins79436471939173

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

8/17/23 16:23
8/15/23
LYELLyell Immunopharma, Inc.DEHealthDrugPharmaceutical PreparationsKlausner RichardCADS-1322.280-58-13,899I
9/27/22 18:14
9/23/22
LYELLyell Immunopharma, Inc.DEHealthDrugPharmaceutical PreparationsKlausner RichardCADS-716.400-1103,957I
1/9/18 21:05
1/8/18
JUNOJuno Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagKlausner RichardWADS-61348.210-13-2729D
12/22/17 16:58
12/21/17
JUNOJuno Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagKlausner RichardWADS-1,61144.760-36-5741D
9/8/17 19:29
9/7/17
JUNOJuno Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagKlausner RichardWADS-51242.660-12-2777D
8/9/17 19:43
8/7/17
JUNOJuno Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagKlausner RichardWADS-36430.340-12-1789D
7/7/17 19:49
7/7/17
JUNOJuno Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagKlausner RichardWADS-70529.390-24-3801D
6/9/17 19:37
6/7/17
JUNOJuno Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagKlausner RichardWADS-56623.600-24-3825D
6/24/16 17:56
6/24/16
JUNOJuno Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagKlausner RichardWADS-48840.7133-12-1847D-14-21920061-7-4-25-22-51
5/20/16 17:35
5/18/16
JUNOJuno Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagKlausner RichardWADS-48040.0030-12-1859D-14-2610-6-723-127-17-25
4/19/16 19:17
4/15/16
JUNOJuno Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagKlausner RichardWADS-51542.9033-12-1871D-31-133131993-12-11-33-34
3/22/16 18:42
3/22/16
JUNOJuno Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagKlausner RichardWADS-48040.0033-12-1882D-36-10-1346-206-9-867-29-51
3/2/16 21:00
3/2/16
JUNOJuno Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagKlausner RichardWADS-97040.4233-24-3894D-145-2926481218-5-7-122-27-44
12/17/15 19:01
12/15/15
JUNOJuno Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagKlausner RichardWADS-54945.7133-12-1918D-1010-16-18-55-12-28-12-5-56
11/16/15 17:16
11/13/15
ILMNIllumina IncDEElectrLabEqLaboratory Analytical InstrumKlausner RichardCAOSVP,ChieS-119163.5233-1-323D74-10-17-20212482310-9-19-20
11/13/15 20:00
11/13/15
JUNOJuno Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagKlausner RichardWADS-59449.5133-12-1930D1526161-11-477-10-36-24-37
10/16/15 19:00
10/15/15
JUNOJuno Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagKlausner RichardWADS-40050.0033-8-1942D-211462770-2-60-32-11-44
10/13/15 06:13
10/12/15
JUNOJuno Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagKlausner RichardWADS-80050.0033-16-2950D-18-44033244-4-32-27-15-43
9/29/15 16:26
9/28/15
ILMNIllumina IncDEElectrLabEqLaboratory Analytical InstrumKlausner RichardCAOSVP,ChieS-73173.20330-224D1041-11-22-19-16-20-124-4-1511-76
7/17/15 18:00
7/15/15
JUNOJuno Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagKlausner RichardWADS-42753.3433-8-1966D-1-20-195-2-3-12-21-8-29-41
6/25/15 17:30
6/23/15
JUNOJuno Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagKlausner RichardWADS-41852.2933-8-1974D-511-20-150-5112-21-9-10
3/11/15 19:46
3/10/15
ILMNIllumina IncDEElectrLabEqLaboratory Analytical InstrumKlausner RichardCAOSVP,ChieS-227191.7533-1-525D2591672-5-3-1-4-12-2134-19

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact